HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alistair Burns Selected Research

Dizziness (Lightheadedness)

1/2020Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial.
6/2007Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alistair Burns Research Topics

Disease

51Dementia (Dementias)
01/2022 - 07/2000
42Alzheimer Disease (Alzheimer's Disease)
01/2022 - 05/2002
14Cognitive Dysfunction
01/2021 - 07/2000
5Stroke (Strokes)
01/2022 - 01/2011
5Psychotic Disorders (Schizoaffective Disorder)
05/2019 - 12/2003
4Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2017 - 10/2003
4Parkinson Disease (Parkinson's Disease)
01/2017 - 06/2009
3Mixed Dementias
01/2017 - 05/2013
3Ischemic Stroke
01/2017 - 11/2013
2Dizziness (Lightheadedness)
01/2020 - 06/2007
2Neurobehavioral Manifestations
01/2017 - 08/2011
2Frontotemporal Dementia (Semantic Dementia)
01/2017 - 08/2011
2Intracranial Embolism
03/2012 - 05/2006
2Neurodegenerative Diseases (Neurodegenerative Disease)
06/2011 - 07/2000
1Atherosclerosis
01/2022
1Herpes Zoster
10/2021
1COVID-19
11/2020
1Hallucinations (Hallucination)
01/2020
1Parkinsonian Disorders (Parkinsonism)
11/2014
1Poisoning
11/2014
1Hemorrhagic Stroke
11/2013
1Down Syndrome (Down's Syndrome)
11/2012
1Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
09/2011
1Delirium
08/2010
1Hypertension (High Blood Pressure)
11/2007
1Vomiting
06/2007
1Nausea
06/2007
1Lewy Body Disease (Lewy Body Dementia)
11/2006
1Atrophy
11/2005
1Sleepiness
10/2005
1Schizophrenia (Dementia Praecox)
12/2003
1Vascular Diseases (Vascular Disease)
03/2003
1Hearing Loss (Hearing Impairment)
03/2003

Drug/Important Bio-Agent (IBA)

14Pharmaceutical PreparationsIBA
10/2021 - 11/2006
14Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2017 - 03/2003
13Donepezil (Aricept)FDA LinkGeneric
12/2017 - 03/2003
11Memantine (Namenda)FDA Link
12/2017 - 11/2006
9Antipsychotic Agents (Antipsychotics)IBA
11/2020 - 10/2005
5Rivastigmine (Exelon)FDA LinkGeneric
01/2017 - 11/2006
4Galantamine (Galanthamine)FDA LinkGeneric
01/2017 - 11/2006
4Biological ProductsIBA
03/2015 - 12/2003
3CholesterolIBA
01/2022 - 11/2015
3Mirtazapine (Rexer)FDA LinkGeneric
10/2021 - 07/2011
3Cholinergic Agents (Cholinergics)IBA
01/2020 - 06/2007
3Vitamin EFDA LinkGeneric
01/2017 - 11/2006
3LDL CholesterolIBA
01/2017 - 11/2013
3LipidsIBA
01/2017 - 11/2013
3Antidepressive Agents (Antidepressants)IBA
02/2013 - 07/2011
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2017 - 08/2011
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2017 - 08/2011
2oxidized low density lipoproteinIBA
01/2017 - 11/2013
2Sertraline (Zoloft)FDA LinkGeneric
02/2013 - 07/2011
2latrepirdine (dimebon)IBA
06/2011 - 07/2008
2Acetylcholine (Acetylcholine Chloride)FDA Link
10/2007 - 03/2003
2Neurotransmitter Agents (Neurotransmitter)IBA
10/2007 - 03/2003
2Apolipoproteins E (ApoE)IBA
01/2007 - 01/2006
2ApolipoproteinsIBA
01/2007 - 01/2006
2Risperidone (Risperdal Consta)FDA LinkGeneric
01/2006 - 10/2005
1Herpes Zoster VaccineIBA
10/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Minocycline (Cyclops)FDA LinkGeneric
01/2020
1Amyloid (Amyloid Fibrils)IBA
01/2017
1antineoplaston A10 (A 10)IBA
01/2017
1ORALIT (ORS)IBA
11/2014
1PesticidesIBA
11/2014
1propylene diquat (PDQ(+))IBA
09/2011
1Histamine Antagonists (Antihistamines)IBA
06/2011
1TabletsIBA
08/2010
1Nootropic Agents (Nootropics)IBA
11/2007
1MetalsIBA
11/2006
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
09/2006
1Fumigant 93 (D-D)IBA
09/2006
1AnticoagulantsIBA
05/2006
1Cholinergic Antagonists (Anticholinergics)IBA
10/2005
1Estrogens (Estrogen)FDA Link
12/2003
1Dopamine Receptors (Dopamine Receptor)IBA
12/2003
1Apolipoprotein E4IBA
12/2003
1Tacrine (Cognex)FDA Link
03/2003
1EnzymesIBA
03/2003
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
03/2003
1N-Methylaspartate (NMDA)IBA
03/2003
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
03/2003
1CreatineIBA
12/2002
1N-acetylaspartate (N-acetyl aspartate)IBA
12/2002

Therapy/Procedure

13Therapeutics
01/2019 - 11/2008
9Activities of Daily Living (ADL)
01/2017 - 07/2000
5Drug Therapy (Chemotherapy)
12/2017 - 10/2007
4Self-Help Devices (Assistive Technology)
01/2021 - 10/2013
3Cognitive Training
01/2019 - 05/2013
3Home Nursing (Nursing, Home)
12/2015 - 10/2005
3Phototherapy (Light Therapy)
08/2009 - 11/2004
2Aromatherapy
01/2011 - 11/2006
1Patient Discharge
10/2021
1Length of Stay
10/2021
1Inappropriate Prescribing
01/2017
1Terminal Care (Care, Terminal)
11/2011
1Long-Term Care
02/2011
1Institutionalization (Institutionalized Persons)
07/2009
1Microbubbles
05/2006
1Hearing Aids (Hearing Aid)
03/2003